Table 5

Outcomes of patients with stage I nonseminomas
Surveillance Chemotherapy Total
(n=36) (n=4) (n=40)
Disease relapsed (n) 9 (25.0%) 0 (0%) 9 (22.5%)
Site
  Retroperitoneum 8 (88.9%)
  Mediastinum 1 (11.1%)
  Lung 1 (11.1%)
Time to relapse (months) 2–13 (mean 6)
Treatment at relapse (n)
  Chemotherapy 9
  Surgery 5
Prognosis
  Cause-specific death 0 0 0
  Death of other causes 1 1 2

Kobayashi et al.

Kobayashi et al. Diagnostic Pathology 2013 8:57   doi:10.1186/1746-1596-8-57

Open Data